Clinical trial
Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4)
NCT02428842 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4)
- Lead sponsor
- Institut Curie
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 24, 2013
- Completion date
- October 20, 2020
- Enrollment
- 419 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer